ClinicalTrials.gov
public full text
Public Domain
Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease
NT-proBNP is a major diagnostic and prognostic marker in cardiology, but it is also a new marker for biological inflammation, especially in rheumatology. Its evaluation in chronic inflammatory bowel disease was carried out in a preliminary study, the OPERA study where in a population of 12 patients showed an increase in NT-proBNP correlated with the biological and endoscopic activity of the disease. This larger study is therefore a pilot study that could see NTproBNP as a new biomarker of inflammation in MICI.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#646466
- Protease-serpin-microbiome interactions in inflammatory bowel disease: toward integrated biomarkers of gut health.#645296
- Biomarkers in Inflammatory Bowel Diseases#870577
- IBD Biomarker Discovery and Validation Platform#969561
- Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease#810676
Record · ID 854471
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive